Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sanjeeva Reddy Onteddu

Concepts (124)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
10
2022
520
3.660
Why?
Fibrinolytic Agents
4
2022
139
1.470
Why?
Thrombolytic Therapy
4
2022
127
1.470
Why?
Tissue Plasminogen Activator
3
2020
125
1.430
Why?
Brain Ischemia
5
2022
165
1.300
Why?
Nervous System Diseases
2
2020
100
1.180
Why?
Thrombectomy
2
2020
68
0.930
Why?
Pneumonia, Viral
3
2020
186
0.880
Why?
Coronavirus Infections
3
2020
194
0.870
Why?
Pandemics
5
2020
577
0.850
Why?
Intracranial Thrombosis
1
2020
22
0.780
Why?
Health Services Misuse
1
2020
16
0.760
Why?
Time-to-Treatment
1
2020
74
0.740
Why?
Conflict of Interest
1
2020
24
0.730
Why?
Patient Transfer
1
2020
103
0.720
Why?
Venous Thrombosis
1
2020
102
0.710
Why?
Fabry Disease
1
2019
9
0.700
Why?
Enzyme Replacement Therapy
1
2019
19
0.700
Why?
Ischemic Attack, Transient
1
2019
58
0.680
Why?
Emergency Service, Hospital
2
2020
535
0.670
Why?
Cardiology
1
2020
105
0.660
Why?
Leukoaraiosis
1
2015
1
0.560
Why?
Recovery of Function
2
2019
223
0.540
Why?
Hypoxia-Ischemia, Brain
1
2014
70
0.450
Why?
Hospitalization
4
2021
698
0.450
Why?
Telemedicine
1
2019
449
0.440
Why?
Heart Arrest
1
2014
156
0.420
Why?
Humans
23
2022
54395
0.400
Why?
Aged
10
2021
10139
0.380
Why?
Triage
2
2021
77
0.380
Why?
Autoimmune Diseases
2
2020
116
0.360
Why?
Retrospective Studies
6
2020
6380
0.350
Why?
Endovascular Procedures
2
2022
187
0.350
Why?
Middle Aged
10
2021
13223
0.350
Why?
Immunosuppressive Agents
2
2020
251
0.340
Why?
Male
13
2021
27615
0.300
Why?
Female
13
2021
28675
0.300
Why?
United States
5
2020
5188
0.290
Why?
Arkansas
4
2019
2162
0.270
Why?
Time Factors
4
2020
3273
0.270
Why?
Tomography, X-Ray Computed
3
2020
1213
0.230
Why?
Treatment Outcome
5
2022
5649
0.230
Why?
Follow-Up Studies
2
2020
2399
0.220
Why?
Cavernous Sinus
1
2022
15
0.210
Why?
Carotid-Cavernous Sinus Fistula
1
2022
13
0.210
Why?
Critical Care
2
2021
234
0.200
Why?
Sinus Thrombosis, Intracranial
1
2021
20
0.200
Why?
Myasthenia Gravis
1
2021
17
0.200
Why?
Embolization, Therapeutic
1
2022
99
0.190
Why?
Neuromuscular Diseases
1
2020
30
0.190
Why?
Iodine Compounds
1
2020
7
0.190
Why?
Health Care Sector
1
2020
17
0.190
Why?
Databases, Factual
2
2020
688
0.190
Why?
Multiple Sclerosis
1
2020
74
0.180
Why?
Drug Industry
1
2020
40
0.180
Why?
Brain Edema
1
2020
39
0.180
Why?
Cohort Studies
2
2022
1557
0.180
Why?
alpha-Galactosidase
1
2019
9
0.180
Why?
Administration, Oral
1
2020
472
0.180
Why?
Disease Outbreaks
1
2020
123
0.180
Why?
Hospitals
1
2020
178
0.180
Why?
Fluorocarbons
1
2019
52
0.170
Why?
Hemorrhage
1
2020
203
0.170
Why?
Medicare
1
2020
234
0.170
Why?
Prevalence
3
2020
1028
0.170
Why?
Contrast Media
1
2020
224
0.170
Why?
Neuroprotective Agents
1
2019
133
0.160
Why?
Coronary Angiography
1
2020
411
0.160
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
134
0.160
Why?
Physicians
1
2020
251
0.150
Why?
Referral and Consultation
1
2019
311
0.150
Why?
Adult
5
2020
14352
0.140
Why?
Plasminogen Activators
1
2015
3
0.140
Why?
Statistics, Nonparametric
1
2015
235
0.130
Why?
Forensic Pathology
1
2014
9
0.120
Why?
Prospective Studies
1
2020
2615
0.120
Why?
Autopsy
1
2014
52
0.120
Why?
Analysis of Variance
1
2015
658
0.120
Why?
Malaria, Falciparum
1
2013
12
0.120
Why?
Optic Neuritis
1
2013
19
0.120
Why?
Severity of Illness Index
1
2015
1095
0.100
Why?
Health Behavior
1
2014
276
0.100
Why?
Aged, 80 and over
2
2019
3465
0.100
Why?
Socioeconomic Factors
1
2014
645
0.100
Why?
Risk Factors
2
2019
3961
0.090
Why?
Intubation, Intratracheal
2
2021
130
0.090
Why?
Magnetic Resonance Imaging
1
2015
1650
0.080
Why?
Intracranial Hemorrhages
1
2022
41
0.050
Why?
Cerebral Hemorrhage
1
2022
103
0.050
Why?
Headache
1
2022
80
0.050
Why?
Cranial Sinuses
1
2021
11
0.050
Why?
Arthritis, Psoriatic
1
2020
11
0.050
Why?
Spondylitis, Ankylosing
1
2020
11
0.050
Why?
Disease Susceptibility
1
2021
96
0.050
Why?
Colitis, Ulcerative
1
2020
52
0.050
Why?
Osmolar Concentration
1
2020
85
0.050
Why?
Infarction, Middle Cerebral Artery
1
2020
44
0.050
Why?
Mortality
1
2020
102
0.050
Why?
Neurologic Examination
1
2020
74
0.050
Why?
Neuroimaging
1
2020
91
0.050
Why?
Maximum Tolerated Dose
1
2019
37
0.050
Why?
Registries
1
2022
553
0.050
Why?
Crohn Disease
1
2020
96
0.040
Why?
Arthritis, Rheumatoid
1
2020
128
0.040
Why?
Tertiary Care Centers
1
2019
84
0.040
Why?
Subarachnoid Hemorrhage
1
2020
65
0.040
Why?
Administration, Intravenous
1
2019
77
0.040
Why?
Drug-Eluting Stents
1
2020
115
0.040
Why?
Disability Evaluation
1
2019
103
0.040
Why?
Electronic Health Records
1
2021
207
0.040
Why?
Drug Administration Schedule
1
2019
413
0.040
Why?
Comorbidity
1
2019
669
0.040
Why?
Patient Readmission
1
2019
236
0.040
Why?
Double-Blind Method
1
2019
751
0.040
Why?
Diagnosis, Differential
1
2020
1135
0.040
Why?
Myocardial Infarction
1
2020
440
0.030
Why?
Percutaneous Coronary Intervention
1
2020
336
0.030
Why?
Risk Assessment
1
2019
1375
0.030
Why?
Cross-Sectional Studies
1
2019
1686
0.030
Why?
Antimalarials
1
2013
30
0.030
Why?
Infant
1
2020
3796
0.030
Why?
Child, Preschool
1
2020
4139
0.030
Why?
Adolescent
1
2020
6932
0.020
Why?
Child
1
2020
7316
0.020
Why?
Onteddu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description